Rajesh Khanna, Ph.D., University of Arizona Health Sciences (IMAGE)
Caption
New research shows SARS-CoV-2 promotes pain relief when it infects cells through a common protein receptor, neuropilin-1. The finding gives scientists a novel target for non-opioid pain therapeutics, while also offering an explanation for the unrelenting spread of COVID-19.
Credit
University of Arizona Health Sciences, Kris Hanning
Usage Restrictions
Editorial use only
License
Licensed content